Therapeutic approaches to mucus hypersecretion

Current Allergy and Asthma Reports

Volumn 5, Issue 3, 2005, Pages 243-251

  Yuta, Atsushi ^a   Baraniuk, James N ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ATROPINE METHYL NITRATE; BALSAM; BROMHEXINE; CAMPHOR; CARBOCISTEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CINEOLE; CYSTEINE; DEOXYRIBONUCLEASE; DIQUAFOSOL; DITHIOTHREITOL; DOMIODOL; DORNASE ALFA; ERYTHROMYCIN; EXPECTORANT AGENT; GELSOLIN; GLUCOCORTICOID; GLYCOPYRRONIUM BROMIDE; GUAIACOL; GUAIFENESIN; HYPERTONIC SOLUTION; IODINATED GLYCEROL; IPECAC; IPRATROPIUM BROMIDE; LETOSTEINE; MACROLIDE; MESNA; MUCOLYTIC AGENT; MUSCARINIC M3 RECEPTOR; NITRIC OXIDE SYNTHASE; PLACEBO; POTASSIUM IODIDE; PURINERGIC RECEPTOR STIMULATING AGENT; SOBREROL; STEPRONIN; THEOPHYLLINE; TIOPRONIN; TRYPSIN; WATER;

ACNE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIOXIDANT ACTIVITY; ASTHMA; BREATHING; BRONCHIECTASIS; BRONCHOSPASM; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONGENITAL HYPOTHYROIDISM; COUGHING; CYSTIC FIBROSIS; DIARRHEA; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DYSPEPSIA; DYSPNEA; EMPHYSEMA; EXOCYTOSIS; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL TOXICITY; GLUTATHIONE METABOLISM; GOITER; HEMOPTYSIS; HOARSENESS; HUMAN; INSOMNIA; LARYNGITIS; LOW DRUG DOSE; LYMPHADENOPATHY; MUCUS SECRETION; NAUSEA; OTITIS MEDIA; PANCREAS PSEUDOCYST; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS; STOMATITIS; VAGUS NERVE; VERTIGO; VOMITING;

EID: 20044388361     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0044-6     Document Type: Review

References (41)

1. Reid L: Secretory Cells. Fed Proc 1977, 36: 2703-2707.
2. Verma M, Davidson EA: Mucin gene: structure, expression, and regulation. Glycoconjugate J 1994, 11: 172-179.
3. Brandtzaeg C: Immune functions of human nasal mucosa and tonsils in health and disease. In Immunology of the Lung and Upper Respiratory Tract. Edited by Bienenstock J. New York: McGraw-Hill; 1984:28-95.
4. Braga PC, Allegra L (eds): Drugs in Bronchial Mucology. New York: Raven Press; 1989:1-368.
5. Ziment I: Respiratory Pharmacology and Therapeutics. Philadelphia: WB Saunders; 1988.
6. Rogers DF, Lethem MI (eds): Airway Mucus: Basic Mechanisms and Clinical Perspectives. Basel: Birkhauser; 1997:1-388.
7. Hsu HY, Peacher WG, Chen H: History of Chinese medical science. Bull Orient Arts Inst 1977, 2:6.
8. Majno G: The Healing Hand, Man, and Wound in the Ancient World. Cambridge: Harvard University Press; 1975.
9. Chung KF, Dent G, McCusker M, et al.: Effect of a ginkgolide mixture, BN 52063, in antagonizing skin and platelet response to platelet activating factor. Lancet 1987, 8527:248-251.
10. Richardson P: Oral N-acetyl-cystine: How does it act? Eur J Resp Dis 1987, 70:71-72.
11. Stephan U, Bowing B, Goering U, et al.: Acetylcysteine in chronic treatment of cystic fibrosis. Eur J Respir Dis 1980, 61(Suppl 111):127-131.
12. Boman G, Backer U, Larsson S, et al.: Oral acetyl cystine reduces exacerbation rate in chronic bronchitis, report of a trial organized by the Swedish Society for Pulmonary Disease. Eur J Resp Dis 1983, 64:405-415.
13. Multicenter Study Group: Long term oral acetyl cystine in chronic bronchitis, a double blind controlled study. Eur J Respir Dis 1980, 61(Suppl 111):93-108.
14. Rochat T, Lacroix JS, Jornot L: N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells. J Cell Physiol 2004, 201:106-116.
15. Steen SN, Ziment I, Freeman D, Thomas JS: Evaluation a new mucolytic drug. Clin Pharmacol Ther 1974, 16:58-62.
16. Boonyapiwat B, Forbes B, Steventon GB: Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine. Anal Biochem 2004, 335:91-97.
17. Miskovits G, Szule P, Appel J, Meszaros M: La mucoregolation element important dans le traitement du syndrome bronchitique. Med Klin 1984, 79:88-92.
18. Majima Y, Takeuchi K, Sakakura Y: Effects of myringotomy and orally administered drugs on viscosity and elasticity of middle ear effusions from children with otitis media with effusion. Acta Otolaryngol Suppl (Stockh) 1990, 471:66-72.
19. Schroeder K, Fahey T: Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2004, 4:CD001831.
20. Tsujimoto T, Takano M, Tsuruzono T, et al.: Mediastinal pancreatic pseudocyst caused by obstruction of the pancreatic duct was eliminated by bromhexine hydrochloride. Intern Med 2004, 43:1034-1038.
21. Stetinova V, Herout V, Kvetina J: In vitro and in vivo antioxidant activity of ambroxol. Clin Exp Med 2004, 4:152-158.
22. Petty TL: The national mucolytic study: results of a randomized, double blind, placebo controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 1990, 98:1309-1310.
23. Ferrari S, Donati C, Legnani W: Studio clinico controllato dell'attivata terapeutica del domiodolo. Riv Patol Clin 1981, 36:139-154.
24. Juergens UR, Dethlefsen U, Steinkamp G, et al.: Anti-inflammatory activity of 1,8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med 2003, 97:250-256.
25. Meltzer EO: Intranasal anticholinergic therapy of rhinorrhea. J Allergy Clin Immunol 1992, 90:1055-1064.
26. Gross NJ: Anticholinergic agents. In Pulmonary and Critical Care Pharmacology and Therapeutics. Edited by Leff AR. New York: McGraw-Hill; 1996:535-552.
27. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84:731-765.
28. Gal TJ, Suratt PM, Lu J: Glycopyrrolate and atropine inhalation: comparative effects on normal airway function. Am Rev Respir Dis 1984, 129:871-873.
29. Bronsky EA, Druce H, Findlay SR, et al.: A clinical trial of ipratropium bromide nasal spray in patients with perennial non-allergic rhinitis. J Allergy Clin Immunol 1995, 95:1117-1122.
30. Diamond L, Dockhorn RJ, Grossman J, et al.: A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 1995, 95:1139-1146.
31. Saketkhoo K, Januskiewicz A, Sackner MA: Effects of drinking hot water, cold water, and chicken soup on nasal mucus, velocity and nasal airflow resistance. Chest 1978, 74:408-410.
32. Jones AP, Wallis CE: Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2003, 3:CD001127.
33. Vasconcellos CA, Allen PG, Wohl ME, Stossel TP: Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994, 263:969-971.
34. Brandt T, Breitenstein S, Hardt HV, Tümmler B: DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax 1995, 50:880-882.
35. Claman DM, Bousher HA, Lui J, et al.: Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994, 94:861-869.
36. Goswami SK, Kivity S, Marom Z: Erythromycin inhibits respiratory glycoconjugate secretion from human airway in vivo. Am Rev Respir Dis 1990, 141:72-78.
37. Tamaoki J, Isono K, Sakai N, et al.: Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 1992, 5:234-238.
38. Gotfried MH: Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004, 125(2 Suppl):52S-60S.
39. Iino Y, Okura S, Shiga J, et al.: Histopathological studies on paranasal mucosa from patients treated with erythromycin. J Otolaryngol Jpn 1994, 97:1070-1078.
40. Anonymous: Diquafosol: DE 089, diquafosol tetrasodium, INS 365, INS 365 Ophthalmic, INS 365 Respiratory, KPY 998. Drugs R D 2003, 4:359-362.
41. Poole PJ, Black PN: Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents. Am J Respir Crit Care Med 2003, 2:367-370.